0326 CHMPs
BioCentury & Getty Images

Regulation

CHMP backs GSK’s lupus drug for kidney complication, J&J’s oral MS therapy

Mar 26, 2021 | 9:47 PM GMT

GSK’s Benlysta and J&J’s Ponvory are

Read the full 266 word article

How to gain access

Continue reading with a
two-week free trial.